To match tumors having particular mutations with the best treatments, cancer centers are beginning to set up interdisciplinary teams. The experts range from oncologists who treat patients, to bioinformaticians who interpret genetic data, to researchers who study cancer genetics. The Dana-Farber Cancer Institute in Boston, MA, sequences DNA from tumors and then advises patients of their options for targeted treatments based on the latest studies. Similarly, the Mayo Clinic in Rochester, MN, uses genetic analysis to identify tumors with known targeted treatments and also links cancer patients with clinical trials. Besides benefiting people with cancer in real time, this team approach helps scientists zero in on the research questions that will help future patients the most.